In a report released today, Michael Lavery from Piper Sandler maintained a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of $1.00. The company’s shares closed yesterday at $0.53.
According to TipRanks, Lavery is a 4-star analyst with an average return of 5.7% and a 51.03% success rate. Lavery covers the Consumer Defensive sector, focusing on stocks such as Kellogg, Celsius Holdings, and B&G Foods.
Aurora Cannabis has an analyst consensus of Hold, with a price target consensus of $0.85.
See the top stocks recommended by analysts >>
The company has a one-year high of $1.94 and a one-year low of $0.48. Currently, Aurora Cannabis has an average volume of 4.1M.
Based on the recent corporate insider activity of 14 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ACB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
- Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA
- Here’s What You Missed in Cannabis This Week
- Largest borrow rate increases among liquid names
- Rising High: Exclusive talk with biotech company Tryp Therapeutics
- Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow
